Literature DB >> 1436309

Intraglomerular expression of MHC class II and Ki-67 antigens and serum gamma-interferon levels in IgA nephropathy.

H Yokoyama1, M Takaeda, T Wada, M Ogi, N Tomosugi, T Takabatake, T Abe, M Yoshimura, H Kida, K Kobayashi.   

Abstract

In order to clarify intraglomerular cellular activation and cytokine involvement in IgA nephropathy, the glomerular expression of MHC class II antigens (HLA-DR and DQ) and cellular proliferative nuclear antigen (Ki-67), and serum gamma-interferon (gamma-IFN) levels were evaluated in 49 patients with IgA nephropathy. HLA-DR was detected in all but 4 patients in whom glomerular sclerosis was present. HLA-DQ and Ki-67 were observed in 51 and 38% of the patients, respectively. Proteinuria, recent macroscopic hematuria, mesangial proliferation, and extracapillary and endocapillary lesions were more frequent and more severe in HLA-DQ-positive than in HLA-DQ-negative patients. In 10 patients with acute exacerbation, endocapillary lesions and HLA-DQ and Ki-67 expression were present in 70, 80 and 88%, respectively. Serum gamma-IFN levels were high in the patients (2.0 +/- 0.3 U/ml, n = 40), especially during acute exacerbation (3.4 +/- 1.1 U/ml, n = 9). Glomerular HLA-DO and Ki-67 expression correlated with serum gamma-IFN levels (r = 0.73, p less than 0.01 for HLA-DQ; r = 0.75, p less than 0.01 for Ki-67). Renal biopsy specimens taken before and after prednisolone and/or urokinase therapy were available from 4 patients. There was strong reactivity to HLA-DQ in the glomerular tufts of all 4 pretreatment samples. However, HLA-DQ reactivity disappeared after treatment in 3 samples, concomitant with normalization of serum gamma-IFN levels. We conclude that serum gamma-IFN levels are related to glomerular HLA-DQ and Ki-67 expression and acute exacerbation in patients with IgA nephropathy.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1436309     DOI: 10.1159/000187028

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  9 in total

1.  Phenotypic characterization of cytokine expression in patients with IgA nephropathy.

Authors:  N Yano; M Endoh; Y Nomoto; H Sakai; K Fadden; A Rifai
Journal:  J Clin Immunol       Date:  1997-09       Impact factor: 8.317

2.  Altered synthesis of interferon-gamma and expression of interferon-gamma receptor by peripheral blood mononuclear cells from patients with IgA nephropathy and non-IgA proliferative glomerulonephritis.

Authors:  N Yano; M Endoh; R Naka; F Takemura; Y Nomoto; H Sakai
Journal:  J Clin Immunol       Date:  1996-01       Impact factor: 8.317

Review 3.  Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases.

Authors:  D R Lucey; M Clerici; G M Shearer
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

4.  Profiles of immunoregulatory cytokine production in vitro in patients with IgA nephropathy and their kindred.

Authors:  V Scivittaro; L Gesualdo; E Ranieri; C Marfella; S A Schewn; S N Emancipator; F P Schena
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

5.  Imbalances in serum proinflammatory cytokines and their soluble receptors: a putative role in the progression of idiopathic IgA nephropathy (IgAN) and Henoch-Schönlein purpura nephritis, and a potential target of immunoglobulin therapy?

Authors:  G Rostoker; J C Rymer; G Bagnard; M Petit-Phar; M Griuncelli; Y Pilatte
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

6.  Podocyte expression of MHC class I and II and intercellular adhesion molecule-1 (ICAM-1) in experimental pauci-immune crescentic glomerulonephritis.

Authors:  W Coers; E Brouwer; J T Vos; A Chand; S Huitema; P Heeringa; C G Kallenberg; J J Weening
Journal:  Clin Exp Immunol       Date:  1994-11       Impact factor: 4.330

7.  Increase of both circulating Th1 and Th2 T lymphocyte subsets in IgA nephropathy.

Authors:  K N Lai; R T Ho; C K Lai; C H Chan; P K Li
Journal:  Clin Exp Immunol       Date:  1994-04       Impact factor: 4.330

Review 8.  De novo membrano-proliferative nephritis following interferon therapy for chronic hepatitis C (case study and literature review).

Authors:  Fabrizio Fabrizi; Alessio Aghemo; Gabriella Moroni; Patrizia Passerini; Roberta D'Ambrosio; Paul Martin; Piergiorgio Messa
Journal:  Dig Dis Sci       Date:  2013-12-08       Impact factor: 3.487

9.  Major histocompatibility complex class II expression by intrinsic renal cells is required for crescentic glomerulonephritis.

Authors:  S Li; C Kurts; F Köntgen; S R Holdsworth; P G Tipping
Journal:  J Exp Med       Date:  1998-08-03       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.